Bolt Biotherapeutics Inc (BOLT)

$5.18 -0.09 (-1.73%)
Market Cap 9.94M
Revenue (ttm) 7.69M
Net Income (ttm) -63.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -820.81%
Debt to Equity Ratio 0.00
Volume 3,700
Avg Vol 15,960
Day's Range N/A - N/A
Shares Out 1.92M
Stochastic %K 54%
Beta 0.90
Analysts Hold
Price Target $13.00

Company Profile

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company dBDC-3042, develops dan agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer; and BDC-4182, an next-generation boltbody technology platform that targets claudin 18.2, which is overexpressed in gastric/gastroesophageal junction cancer, pancreat...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 665 9295
Address:
900 Chesapeake Drive, Redwood City, United States
rp6577
rp6577 Sep. 10 at 5:37 PM
$BOLT partnership announcement could come at any moment. They were running a formal process earlier this year
1 · Reply
cb5000calls
cb5000calls Sep. 10 at 11:46 AM
$BDRX $BOLT $SLS why are my shares the only shares that ever get personally called out????? Because I’m the only long that has that real patient to hold every last share and not sell a single one for over 6+ years now?
4 · Reply
Love_To_Learn
Love_To_Learn Sep. 10 at 11:06 AM
$BOLT i do also have your 3.36 active btw apart of the board * lower range other ranges active to on board mechancis
1 · Reply
Love_To_Learn
Love_To_Learn Sep. 10 at 11:05 AM
$CREG u will b involved in this $TANH $BOLT $BDRX $TANH $RFL etc.................
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 10 at 11:03 AM
$BOLT $BDRX bunch more i wont tag @ this time who has the new shares in the float replayign CB 2019 late n 2020 $SLS n who goign to moon 5 other stocks not on ist
1 · Reply
Love_To_Learn
Love_To_Learn Sep. 9 at 5:30 PM
$BOLT need to turn on your low to mid 3's filler on and off rotate it with beud $BDRX for lower board mechanics multiple timer issues for pops highway traffic jam fixing now
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 8 at 9:32 AM
$BOLT Really good write-up that perfectly summarizes BOLT's present situation. So if you want to bring your BOLT knowledge up to date or just discover BOLT, this is required reading. https://beyondspx.com/quote/BOLT/analysis/bolt-biotherapeutics-sharpening-the-immuno-oncology-edge-with-next-gen-isacs-nasdaq-bolt
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 3 at 11:04 AM
$BOLT been shorting u slowly she has lower to go in general
1 · Reply
NoFearHere
NoFearHere Sep. 2 at 1:39 PM
$BOLT Lot of CYCN douchebag salesman
0 · Reply
rp6577
rp6577 Aug. 22 at 4:52 PM
$BOLT a bit of news, perhaps the partnership they have been working on, and this roars
0 · Reply
Latest News on BOLT
Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 14, 2025, 4:05 PM EDT - 4 weeks ago

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025, 4:05 PM EDT - 4 months ago

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

May 8, 2025, 8:00 AM EDT - 4 months ago

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Apr 30, 2025, 4:05 PM EDT - 4 months ago

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Apr 25, 2025, 1:00 PM EDT - 5 months ago

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Mar 25, 2025, 4:30 PM EDT - 6 months ago

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Mar 24, 2025, 4:20 PM EDT - 6 months ago

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Feb 25, 2025, 4:05 PM EST - 7 months ago

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Feb 11, 2025, 4:05 PM EST - 7 months ago

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Nov 7, 2024, 10:00 AM EST - 11 months ago

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

Sep 6, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

Bolt Biotherapeutics Announces Changes to its Board of Directors

Sep 4, 2024, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Announces Changes to its Board of Directors

Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm

Sep 4, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Sep 2, 2024, 11:11 AM EDT - 1 year ago

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions

Sep 2, 2024, 11:00 AM EDT - 1 year ago

Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Aug 31, 2024, 11:25 AM EDT - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm

Aug 31, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Aug 29, 2024, 8:49 PM EDT - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

The Schall Law Firm Urges Investors To Join A Lawsuit For Securities Fraud Against Bolt Biotherapeutics Inc

Aug 28, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Investors To Join A Lawsuit For Securities Fraud Against Bolt Biotherapeutics Inc

A Case Has Been Filed Against Bolt Biotherapeutics Inc For Securities Law Infractions And Stakeholders Are Encouraged To Contact The Schall Law Firm

Aug 27, 2024, 11:00 AM EDT - 1 year ago

A Case Has Been Filed Against Bolt Biotherapeutics Inc For Securities Law Infractions And Stakeholders Are Encouraged To Contact The Schall Law Firm

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 13, 2024, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

BOLT Investors Have Opportunity to Actively Participate Bolt Biotherapeutics, Inc.

Jul 26, 2024, 10:00 AM EDT - 1 year ago

BOLT Investors Have Opportunity to Actively Participate Bolt Biotherapeutics, Inc.

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc.

Jul 25, 2024, 10:00 AM EDT - 1 year ago

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc.

Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on September 3, 2024 in Bolt Lawsuit

Jul 19, 2024, 11:10 AM EDT - 1 year ago

Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on September 3, 2024 in Bolt Lawsuit

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Jul 3, 2024, 4:47 PM EDT - 1 year ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Jun 24, 2024, 3:36 PM EDT - 1 year ago

Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call Transcript

May 17, 2024, 8:37 PM EDT - 1 year ago

Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call Transcript

rp6577
rp6577 Sep. 10 at 5:37 PM
$BOLT partnership announcement could come at any moment. They were running a formal process earlier this year
1 · Reply
cb5000calls
cb5000calls Sep. 10 at 11:46 AM
$BDRX $BOLT $SLS why are my shares the only shares that ever get personally called out????? Because I’m the only long that has that real patient to hold every last share and not sell a single one for over 6+ years now?
4 · Reply
Love_To_Learn
Love_To_Learn Sep. 10 at 11:06 AM
$BOLT i do also have your 3.36 active btw apart of the board * lower range other ranges active to on board mechancis
1 · Reply
Love_To_Learn
Love_To_Learn Sep. 10 at 11:05 AM
$CREG u will b involved in this $TANH $BOLT $BDRX $TANH $RFL etc.................
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 10 at 11:03 AM
$BOLT $BDRX bunch more i wont tag @ this time who has the new shares in the float replayign CB 2019 late n 2020 $SLS n who goign to moon 5 other stocks not on ist
1 · Reply
Love_To_Learn
Love_To_Learn Sep. 9 at 5:30 PM
$BOLT need to turn on your low to mid 3's filler on and off rotate it with beud $BDRX for lower board mechanics multiple timer issues for pops highway traffic jam fixing now
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 8 at 9:32 AM
$BOLT Really good write-up that perfectly summarizes BOLT's present situation. So if you want to bring your BOLT knowledge up to date or just discover BOLT, this is required reading. https://beyondspx.com/quote/BOLT/analysis/bolt-biotherapeutics-sharpening-the-immuno-oncology-edge-with-next-gen-isacs-nasdaq-bolt
0 · Reply
Love_To_Learn
Love_To_Learn Sep. 3 at 11:04 AM
$BOLT been shorting u slowly she has lower to go in general
1 · Reply
NoFearHere
NoFearHere Sep. 2 at 1:39 PM
$BOLT Lot of CYCN douchebag salesman
0 · Reply
rp6577
rp6577 Aug. 22 at 4:52 PM
$BOLT a bit of news, perhaps the partnership they have been working on, and this roars
0 · Reply
goandgo
goandgo Aug. 22 at 6:36 AM
$BOLT why downtrend? dilution or clinical trials failure? should I sell all shares before it gets lower?
0 · Reply
StockTwitsGhost
StockTwitsGhost Aug. 21 at 2:44 PM
$BOLT One of the easiest short calls. Everyday 5%. Like having a personally owned ATM.
1 · Reply
SDBiotechInvestor
SDBiotechInvestor Aug. 20 at 5:14 PM
$CYCN - With the market topping this week and tech plummeting ,$CYCN is a great place to park your money for TRD inlicense news. No downside, whereas you see $BOLT and $PEPG bleed daily. If my theory of beacon biosignals is correct, when the announcement comes sky is the limit.
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Aug. 20 at 4:49 PM
$BOLT will cover at 2 like my buddy Ghost dog been saying, all that profit full porting into $CYCN all for bioturd valoooes
2 · Reply
StockTwitsGhost
StockTwitsGhost Aug. 19 at 9:29 PM
$BOLT was an easy short when the call was made on Aug 06. Sub $2 is the ideal cover zone. ✌🏿🕊️
0 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 18 at 6:02 PM
$BOLT I'm a buyer sub $4 before after they announce trial failure/halting and announce strategic alternatives. GBIO just did it, NERV just did it, and BOLT will do it before EOY
1 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Aug. 18 at 4:00 PM
$BOLT where's bioturd values?
0 · Reply
builderup
builderup Aug. 18 at 1:44 AM
Weekly Watchlist $BOLT $ZVIA $MVST
0 · Reply
Bullbear1010101
Bullbear1010101 Aug. 17 at 11:11 PM
$BOLT quite the trend down
0 · Reply
d_risk
d_risk Aug. 16 at 11:09 PM
$BOLT - Bolt Biotherapeutics, Inc. - 10Q - Updated Risk Factors BOLT flags new risks from global trade tensions, tariffs, and healthcare reform, warning of potential supply chain delays, higher costs, regulatory hurdles, and threats to international growth and product commercialization. #Biotechnology #RegulatoryChallenges #SupplyChainRisk #GlobalTradeTensions #HealthcareReform 🟢 Added 🟠 Removed https://d-risk.ai/BOLT/10-Q/2025-08-14
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW Aug. 16 at 6:38 PM
$BOLT printed 52 week low yesterday, new lows coming in the days and weeks ahead, pressing shall now commence
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Aug. 15 at 6:16 PM
$CYCN Oh boy. BV already deleted his $BOLT posts. When $CYCN has news (thanks Dina), he will delete all his CYCN's too.
2 · Reply